Aytu BioPharma, Inc. (AYTU)
1.99
+0.02
(+1.02%)
USD |
NASDAQ |
Oct 13, 16:00
2.00
+0.01
(+0.50%)
After-Hours: 20:00
Aytu BioPharma Net Income (Quarterly) : -0.015M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.015M |
| March 31, 2026 | -5.618M |
| December 31, 2025 | -10.58M |
| September 30, 2025 | 1.965M |
| June 30, 2025 | -19.88M |
| March 31, 2025 | 3.94M |
| December 31, 2024 | 0.665M |
| September 30, 2024 | 1.093M |
| June 30, 2024 | -3.378M |
| March 31, 2024 | -2.288M |
| December 31, 2023 | 0.619M |
| September 30, 2023 | -7.473M |
| June 30, 2023 | -2.457M |
| March 31, 2023 | -7.20M |
| December 31, 2022 | -6.693M |
| September 30, 2022 | -0.701M |
| June 30, 2022 | -16.09M |
| March 31, 2022 | -53.07M |
| December 31, 2021 | -11.55M |
| September 30, 2021 | -27.85M |
| June 30, 2021 | -19.00M |
| March 31, 2021 | -25.46M |
| December 31, 2020 | -9.525M |
| September 30, 2020 | -4.306M |
| June 30, 2020 | -3.145M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.332M |
| December 31, 2019 | -0.2142M |
| September 30, 2019 | -4.929M |
| June 30, 2019 | -14.53M |
| March 31, 2019 | -4.496M |
| December 31, 2018 | -4.658M |
| September 30, 2018 | -3.446M |
| June 30, 2018 | 0.5476M |
| March 31, 2018 | -2.818M |
| December 31, 2017 | -3.673M |
| September 30, 2017 | -4.245M |
| June 30, 2017 | -3.04M |
| March 31, 2017 | -5.216M |
| December 31, 2016 | -4.817M |
| September 30, 2016 | -5.724M |
| June 30, 2016 | -15.30M |
| March 31, 2016 | -7.274M |
| December 31, 2015 | -3.332M |
| September 30, 2015 | -2.276M |
| March 31, 2015 | -1.842M |
| February 28, 2015 | -0.0099M |
| November 30, 2014 | -0.0158M |
| August 31, 2014 | -0.0112M |
| May 31, 2014 | -0.0118M |
| February 28, 2014 | -0.0222M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 16.11M |
| Total Expenses (Quarterly) | 16.12M |
| EPS Diluted (Quarterly) | -0.0008 |
| Enterprise Value | 13.15M |
| Gross Profit Margin (Quarterly) | 59.90% |
| Profit Margin (Quarterly) | -0.09% |
| Earnings Yield | -83.78% |
| Normalized Earnings Yield | -83.77 |